Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Spada

Showing results (31-40 of 120) with videos related to

Pageof 12
Sort By:
Journal of Agricultural and Food Chemistry|February 11, 2011
Corticosteroid hormone receptors and prereceptors as new biomarkers of the illegal use of glucocorticoids in meat productionSara Divari, Francesca T Cannizzo, Federica Uslenghi, et al.
World Journal of Gastroenterology|March 29, 2021
Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3<sup>rd</sup>-line treatmentAngela Lamarca, Mauro Cives, Louis de Mestier, et al.
Cancer Treatment Reviews|June 18, 2026
Re-challenge strategies in neuroendocrine tumours: adding another arrow in the quiver?Lavinia Benini, Davide Ciardiello, Francesca Spada, et al.
European Journal of Human Genetics : EJHG|February 28, 2008
Molecular and cytogenetic analysis of the spreading of X inactivation in a girl with microcephaly, mild dysmorphic features and t(X;5)(q22.1;q31.1)Roberto Giorda, M Clara Bonaglia, Greta Milani, et al.
Frontiers in Oncology|August 8, 2024
Pneumonectomy for broncho-pulmonary carcinoids: a single centre analysis of surgical approaches and patient outcomesCristina Diotti, Luca Bertolaccini, Lara Girelli, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological ManagementFrancesca Spada, Roberta E Rossi, Elda Kara, et al.
Endocrine-Related Cancer|December 15, 2016
Regression of advanced neuroendocrine tumors among patients receiving placeboVito Amoroso, Giorgio Maria Agazzi, Elisa Roca, et al.
International Journal of Surgery (London, England)|June 16, 2015
Small intestinal neuroendocrine tumors with liver metastases and resection of the primary: Prognostic factors for decision makingEmilio Bertani, Massimo Falconi, Chiara Grana, et al.
Neuroendocrinology|July 26, 2017
Everolimus in Combination with Octreotide Long-Acting Repeatable in a First-Line Setting for Patients with Neuroendocrine Tumors: A 5-Year UpdateEmilio Bajetta, Laura Catena, Sara Pusceddu, et al.
Frontiers in Endocrinology|May 14, 2021
Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin AnalogsElisa Lenotti, Andrea Alberti, Francesca Spada, et al.
Pageof 12

Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
Journal of Agricultural and Food Chemistry|February 11, 2011
Corticosteroid hormone receptors and prereceptors as new biomarkers of the illegal use of glucocorticoids in meat productionSara Divari, Francesca T Cannizzo, Federica Uslenghi, et al.
World Journal of Gastroenterology|March 29, 2021
Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3<sup>rd</sup>-line treatmentAngela Lamarca, Mauro Cives, Louis de Mestier, et al.
Cancer Treatment Reviews|June 18, 2026
Re-challenge strategies in neuroendocrine tumours: adding another arrow in the quiver?Lavinia Benini, Davide Ciardiello, Francesca Spada, et al.
European Journal of Human Genetics : EJHG|February 28, 2008
Molecular and cytogenetic analysis of the spreading of X inactivation in a girl with microcephaly, mild dysmorphic features and t(X;5)(q22.1;q31.1)Roberto Giorda, M Clara Bonaglia, Greta Milani, et al.
Frontiers in Oncology|August 8, 2024
Pneumonectomy for broncho-pulmonary carcinoids: a single centre analysis of surgical approaches and patient outcomesCristina Diotti, Luca Bertolaccini, Lara Girelli, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological ManagementFrancesca Spada, Roberta E Rossi, Elda Kara, et al.
Endocrine-Related Cancer|December 15, 2016
Regression of advanced neuroendocrine tumors among patients receiving placeboVito Amoroso, Giorgio Maria Agazzi, Elisa Roca, et al.
International Journal of Surgery (London, England)|June 16, 2015
Small intestinal neuroendocrine tumors with liver metastases and resection of the primary: Prognostic factors for decision makingEmilio Bertani, Massimo Falconi, Chiara Grana, et al.
Neuroendocrinology|July 26, 2017
Everolimus in Combination with Octreotide Long-Acting Repeatable in a First-Line Setting for Patients with Neuroendocrine Tumors: A 5-Year UpdateEmilio Bajetta, Laura Catena, Sara Pusceddu, et al.
Frontiers in Endocrinology|May 14, 2021
Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin AnalogsElisa Lenotti, Andrea Alberti, Francesca Spada, et al.
Pageof 12